Ecklonia cava polyphenol (ECP) is a potent antioxidant and procirculatory agent that may contribute to improvement of endurance performance during highly intense exercise. This study evaluated the acute effect of an ECP-supplemented drink against a placebo on maximum endurance capacity and related physiological parameters. Twenty men 18-23 yr old volunteered as participants. Each performed 2 randomized trials with a 1-week interval between them. One trial was with ECP and the other with a placebo drink. Participants in this randomized, placebo-controlled, crossover design ingested either a placebo or ECP drink 30 min before each exercise trial. Time to exhaustion, VO 2max , and postexercise blood glucose and lactate levels were evaluated. ECP supplementation increased time to exhaustion (2.39 min) compared with placebo. This result was accompanied by a 6.5% higher mean VO 2max in the ECP group, although the difference was not statistically significant. The blood glucose level in the ECP group at 3 min after exhaustive exercise was significantly higher than that of the placebo group (+ 9.9%). The postexercise blood lactate levels in the ECP group showed a decreasing trend compared with placebo, but it was nonsignificant. This study was not able to determine any physiological mechanisms behind the improved endurance performance, but, based on these results, it is speculated that the ECP supplementation may have contributed to enhanced oxidation of glucose and less production of lactate during intense exercise, possibly by its free-radical-scavenging and procirculatory activities. However, careful verification is required to elucidate the correct mechanism.
During highly intense exercise, the capacity for aerobic metabolism is a major factor in determining an individual's endurance performance (Mortensen, Damsgaard, Dawson, Secher, & González-Alonso, 2008) . Previously, research efforts to improve endurance performance focused on effective supplementation of carbohydrate and hydration, leading to the development of many popular sports drinks based on carbohydrate and electrolytes (Collardeau, Brisswalter, Vercruyssen, Audiffren, & Goubault, 2001; Latzka & Sawka, 2000) . Although carbohydrate supplementation contributes to reduced use of hepatic glycogen reserves and thus can increase exercise time in moderately intense and prolonged exercise, it does not increase exercise time, promote aerobic metabolism, or reduce lactate accumulation in highly intense exercise (McConell, Canny, Daddo, Nance, & Snow, 2000; McConell, Snow, Proietto, & Hargreaves, 1999) . Therefore, it appears necessary to adopt "catalytic" mechanisms to promote aerobic metabolism in addition to a simple supplementation of carbohydrates to improve endurance performance in highly intense exercise (Bloomer, Goldfarb, & McKenzie, 2006; Reid, 2008; Wang et al., 2008) . One promising mechanism is the use of antioxidants, based on the many studies indicating that highly intense exercise leads to oxidative stress, which negatively affects muscle contraction (Ginsburg et al., 1996) . During intense aerobic exercise and the resulting dramatic increases in oxygen consumption, mitochondrial production of free radicals can exceed the intrinsic antioxidant defense capacity, leading to both muscle fatigue and oxidative stress in the circulatory system, which is responsible for delivery of oxygen (Allen, Lamb, & Westerblad, 2008; Davies, Quintanilha, Brooks, & Packer, 1982; Machefer et al., 2004) . Many antioxidants have been evaluated and shown to have some favorable effects alone or in combination in reducing oxidative stress generated during intense exercise (Baskin et al., 2000; Margaritis, Palazzetti, Rousseau, Richard, & Favier, 2003; Powers & Hamilton, 1999) .
More recently, several studies reported the significant beneficial antioxidant effects of natural polyphenols in exercise-induced oxidative stress (Morillas-Ruiz, Villegas, López, Vidal-Guevara, & Zafrilla, 2006; Panza et al., 2008) . Polyphenols from Ecklonia species have been shown to have interesting biological properties that may be useful in sports applications such as improvement in performance, resistance to injury, and recovery. In vitro and in vivo studies report that these polyphenols activate plasmin (Fukuyama et al., 1990; Fukuyama et al., 1989) , dilate blood vessels (Hong et al., 2006) , and have antioxidant activities (Ahn et al., 2007; Shin, Hwang, Kang, & Lee, 2006) . Kang et al. (2003) reported that serum antioxidant activity measured by FRAP was enhanced 30 min after oral administration, suggesting that this material is absorbed into the bloodstream within 30 min and may show an acute effect. Kang et al. also reported that major compounds of Ecklonia cava polyphenol (ECP) in vitro scavenged 50% of DPPH free radical at the concentration range of 7-8 μg/ml. Hong et al. reported significant reduction of serum angiotensin-converting enzyme and vasodilation at a dose of 50 mg · kg -1 · day -1 in hypertensive rats. One of the notable activities that has not been reported in other types of polyphenol is antiplasmin inhibitory activity, which might be involved in enhancing blood flow. Fukuyama et al. (1990 Fukuyama et al. ( , 1989 reported that major compounds of ECP, such as dieckol, 6,6′-bieckol, 8,8′-bieckol, and phlorofucofuroeckol, inhibit 50% of antiplasmin activity at concentrations as low as 0.3-0.8 μg/ml. Myung et al. (2005) reported cognitive enhancement via enhancement of acetylcholine level in mouse brain with a 7-day oral dose of 0.2-1 mg · kg -1 · day -1 phlorofucofuroeckol and dieckol ( Figure 1 ). However, no research focusing on exercise performance or energy metabolism has been reported for these polyphenols. Because the antioxidant and procirculatory effects of these polyphenols might contribute to improved aerobic metabolism during highly intense exercise, this study evaluated the effect of preexercise ECP supplementation on endurance performance during highly intense exercise among college students.
Materials and Methods

Materials
Livechem, Inc. (Jeju, Korea), supplied a sample of foodquality ECP. The sample was extracted from Ecklonia cava collected from Cheju Island in Korea. The total polyphenol content of the sample as phloroglucinol equivalent (Singleton, Orthofer, & Lamuela-Raventos, 1999 ) was 98.5% (w/w). The main polyphenolic compounds in the sample were found to be 6,6′-bieckol, 8,8′-bieckol, dieckol, and phlorofucofuroeckol, which were reported previously (Hwang, Chen, Nines, Shin, & Stoner, 2006; Shin et al., 2006) , as determined by high-performance liquid chromatography (Waters, column: Spherisorb S 10 ODS2 column [20 × 250 mm]; eluent: 30% aqueous methanol; flow rate: 3.5 ml/min). The structures of these polyphenols are shown in Figure 1 .
Experimental Drink
The composition of the placebo and test drinks was based on a commercially available popular sport drink. The 100-ml placebo drink contained 0.49 g of sodium chloride, 2 mg of potassium chloride, 20 mg of calcium chloride, 0.6 g of magnesium chloride, 6.7 g of sugar, and water. The test (ECP) drink additionally contained 40 mg of ECP per 100 ml.
Participants
Twenty male college students 18-23 years of age were recruited to participate in this study. Their characteristics are presented in Table 1 . Participants were not dedicated athletes but had been regularly exercising a minimum of 1 hr for an average of 5 ± 2 times/week within 50% of their VO 2max . No participant had a history of any significant medical disorder, and none had taken any antioxidant supplements for at least 6 months before the study. They were instructed to refrain from making any significant changes in diet and physical activity and to abstain from anti-inflammatory or analgesic drugs throughout the study. All participants gave written informed consent to participate in the study, which was approved by the institutional review board of Korea National Sports University.
Experimental Design
Anthropometric measurements were taken before the study. Height and body weight in standing position were measured with light clothing and no shoes. Body weight and percent body fat were measured using InBody 4.0 (Biospace, Seoul, Korea), which is capable of body-fat analysis by the bioimpedance method. Body-mass index was calculated from height and body weight.
The participants performed a graded exercise test on a treadmill (Bothell, WA, USA) to assess maximal oxygen consumption (VO 2max ) using a modified Bruce protocol (starting with 90 m/min at 6° slope, increasing by 20-m/ min increments every 2 min). VO 2max was measured by analyzing exhaled gases from each participant using a gas analyzer (Cosmed, Italy). The gas analyzer was calibrated before each oxygen-consumption test according to the manufacturer's guidelines using a calibration gas composed of 4% CO 2 , 16% O 2 , and 80% N 2 (KMTEC, Italy).
To assess the effect of ECP supplementation on endurance performance, each participant performed two VO 2max treadmill tests with a 1-week interval between tests. The participants were instructed to refrain from any physical activity other than their normal daily activities on the 2 days preceding the test. Without controlling the time of day, the participants reported to the study room at different designated times for each treatment. In each visit, the participants drank 180 ml of either the ECP or the placebo drink 30 min before an exercise trial.
Application of ECP and placebo was double-blinded and randomized, with half the participants ingesting the placebo drink and the other half ingesting the ECP drink during the first trial and all then ingesting the other drink in the second trial. Before the trials, participants were instructed in the use of the Borg scale for rating of perceived exertion (Borg, 1982) to indicate when they were approximately 1 min from exhaustion. Each exercise trial was performed on a motor-driven treadmill with a 6% incline fixed throughout the test. The protocol consisted of 4 min of warm-up, 30 min of moderately intense exercise at the speed corresponding to the predetermined VO 2max , and a subsequent gradient exercise in which the velocity was increased by 20 m/min every 1 min until voluntary exhaustion. Time to exhaustion and VO 2max were measured. Time to exhaustion was defined as the time spent until exhaustion after completing the moderately intense 30 min of exercise to evaluate endurance ability against the highly intense exhaustive exercise. VO 2max was considered to have been achieved if the participant met at least two of the following criteria: a respiratoryexchange ratio (RER) ≥1.15, plateau of VO 2 during the last stage of exercise, or maximal heart rate within ±10 beats/min of predicted values. Heart rate was measured using a Polar heart-rate monitor (Polar Electro, Finland) at rest and during (10, 20, 30 min) and after (0, + 3, + 5, + 15, + 30, + 60 min) endurance exercise.
To measure blood glucose (mg/dl) and blood lactate (mmol/L), small fingertip blood samples (~25 μl) were taken at rest and 0, 3, 5, 15, 30, 60 min after exercise using an Accu-Chek Softclix lancet device (Accu-Chek Compact System, Roche Diagnostics, Indianapolis, IN, USA). Blood glucose was measured with an Accu-Chek compact meter with less than 3% variability. Blood lactate was measured with a YSI 1500 Sport lactate analyzer (YSI Inc., Yellow Springs, OH, USA) with less than 2% variability.
Statistical Analysis
All data were analyzed using one-way repeated-measures ANOVA followed by post hoc testing using the Student's Newman-Keul method, and p < .05 was considered statistically significant. All values are presented as M ± SD. All analyses were performed with SPSS for Windows, version 10.0 (SPSS Inc., Chicago). 
Results
The 30 min of fixed-speed exercise steadily increased heart rate, VO 2 , and RER in both the ECP and placebo groups ( Table 2 ). The exercise intensity during the period was in the range of 60-80% of VO 2max , and there was no significant difference in those parameters between treatments during the period. However, there were slightly increasing and decreasing trends in VO 2 and RER, respectively, in the ECP treatment. The ECP group exhibited significantly greater time to exhaustion (2.39 min, p < .05) than the placebo group (Figure 2b ). This result was accompanied by a 6.5% higher mean VO 2max in the ECP group, although the difference was not statistically significant ( Figure 2a) .
As shown in Figure 3 , the postexercise blood glucose levels in both groups were remarkably elevated when compared with that of the resting state (p < .001). Both groups showed a peak value at 3 min after exhaustion. ECP supplementation showed higher mean blood glucose levels than placebo at 0, 3, 5, and 15 min after exercise. The blood glucose level in the ECP group shortly after exhaustive exercise (3 min) was significantly higher than in the placebo group (+ 9.9%, p < .05). By 30 min after exercise the glucose level in both groups had returned to resting levels.
As shown in Figure 4 , the mean blood lactate levels in the placebo and ECP groups were remarkably increased compared with the resting levels (p < .001). ECP supplementation showed lower trends in blood lactate level at 0, 3, 5, and 15 min after exercise than placebo by 2.7%, 8.3%, 10.8%, and 4.3%, respectively, but it was now statistically significant. By 30 min after exercise the glucose level in both groups had returned to resting levels. 
Discussion
This study evaluated the acute effects of ECP supplementation on endurance performance in an exhaustive exercise trial and the corresponding physiological markers in college students. The ECP group showed a significant delay in time to exhaustion (2.39 min, p < .05) accompanied by a small insignificant trend toward a higher VO 2max . This study cannot determine any physiological mechanisms behind the improved endurance performance, but the significant delay in exhaustion accompanied by an insignificant small trend toward lower postexercise blood lactate level in the ECP group relative to the placebo group suggests that ECP supplementation may have contributed to less production or enhanced removal of lactate during intense exercise. Both groups showed significantly elevated levels of blood glucose after exhaustive exercise. This phenomenon is thought to be caused by an exercise-induced hepatic glucose production that exceeds the peripheral glucose uptake and is observed during and after highly intense endurance exercise (Howlett, Febbraio, & Hargreaves, 1999; Howlett, Watt, Hargreaves, & Febbraio, 2003; Kjaer, Kiens, Hargreaves, & Richter, 1991; Sonne & Galbo, 1985) . Increased blood glucose during intense exercise was reported to be elevated 18-30% in 20 min of exercise at ~80% VO 2max in endurance-trained men (Howlett et al., 1999; Howlett et al., 2003) . Those data are comparable to the postexercise increases in blood glucose of 21-30% and 12-22% in our ECP and placebo trials, respectively. The observation that blood glucose levels peaked at 3 min after exhaustive exercise was also reported by several researchers Marliss et al., 2000) . On the other hand, the postexercise lactate levels increased by 7.1 and 8.6 times in the ECP and placebo trials, respectively, compared with the resting level. Those levels in both trials peaked at 3 min after exhaustion. Such a high increase and similar time to reach the peak in lactate level after intensive exercise have also been reported by other researchers (Marliss et al., 2000 , Medbo & Toska, 2001 . The magnitude of the increase in postexercise blood glucose was significantly greater in the ECP group than the placebo group, indicating that ECP supplementation induced greater output of hepatic glucose or attenuation of glucose uptake into peripheral tissues. Based on the additional observation that blood lactate level in the ECP trial reached a level similar to that with placebo 2.39 min later, and on the assumption that hepatic glucose output and lactate removal from the blood are not different between treatments, we can speculate that ECP supplementation may have contributed to attenuation of glucose consumption and lactate production during highly intense exercise, possibly by enhancing aerobic metabolism.
Capacity of aerobic metabolism during highly intense exercise depends on efficient blood supply to the contracting muscle (Mortensen et al., 2008) . However, during intense aerobic exercise, when oxygen consumption is dramatically increased, mitochondrial production of free radicals can exceed the intrinsic antioxidant defense capacity (Davies et al., 1982; Machefer et al., 2004) , exerting oxidative stress on endothelial cells, which are responsible for increases in peripheral blood supply via inducing vasodilation (Yung, Leung, Yao, Chen, & Huang, 2006) . It is also known that intense exercise induces acute platelet activation, which suppresses blood flow (Li, He, Blombäck, & Hjemdahl, 2007) . Both effects during highly intense exercise might be involved in a compromised peripheral blood supply to contracting muscle tissues.
Some studies have reported favorable effects of antioxidant supplementation in exercise-induced oxidative stress. Morillas-Ruiz et al. (2006) reported that ingestion of 2.3 g of anthocyanin-rich polyphenolic antioxidants from fruits during exercise significantly reduced oxidative stress after 90 min exercise at 70% of VO 2max in cyclists. Panza et al. (2008) reported that drinking green tea reduced lipid hydroperoxide and increased reduced glutathione and FRAP in young men undergoing resistance exercise. There also are studies that failed to show any significant effect using antioxidants (Clarkson & Thompson, 2000) . Based on the previous studies reporting that the polyphenolic compounds in ECP are potent free-radical scavengers and that oral administration of ECP increased the antioxidant power of the blood (Kang et al., 2003) and suppressed oxidative stress in plasma, red blood cells, liver, and kidney in an animal model (Iwai, 2008) , we speculate that ECP supplementation may have contributed to the protection of endothelial function during intense exercise. Based on reports showing vasodilatory effects of ECP in hypertensive animals (Hong et al., 2006) and potent in vitro plasmin-activating effects of major compounds of ECP, such as dieckol and phlorofucofuroeckol (Fukuyama et al., 1990; Fukuyama et al., 1989) , we further speculate that ECP supplementation may have contributed to enhanced blood flow. However, those possibilities need to be verified in the future. ECP improved endurance performance in an acute trial with a relatively low dose. Such an effect of ECP at a low dose might be caused by synergistic combination of its free-radical-scavenging, vasodilatory, and plasminactivating activities. Although further studies are needed to clarify the mechanism, this study suggests that a new approach using a combination of antioxidant and procirculatory effects to enhance endurance performance may be worth investigating further.
There are other possible mechanisms to be carefully studied in the future that might have been involved in the ECP-induced improvement of endurance performance. Based on observation of a decreasing trend in RER with ECP supplementation, though it was not significant, ECP might have contributed to enhanced utilization of fat. In addition, ECP supplementation might have been involved in accelerating lactate removal.This study demonstrated the effect of ECP on enhanced endurance performance for the first time. However, to verify the speculative mechanisms such as antioxidant and procirculatory functions that might have been involved in this effect, further studies on antioxidant, vascular, and hemostatic markers are needed. Furthermore, repeated-dose or higher-dose studies in untrained and trained participants in various exercise conditions will be desirable to more comprehensively understand the physiological impact of ECP in endurance exercise.
